1. Home
  2. MUX vs AURA Comparison

MUX vs AURA Comparison

Compare MUX & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

N/A

Current Price

$9.17

Market Cap

733.1M

ML Signal

N/A

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

N/A

Current Price

$6.88

Market Cap

631.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MUX
AURA
Founded
1979
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
733.1M
631.6M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
MUX
AURA
Price
$9.17
$6.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
6
Target Price
★ $28.40
$16.60
AVG Volume (30 Days)
★ 1.3M
683.9K
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.10
N/A
Revenue
★ $197,553,000.00
N/A
Revenue This Year
$19.23
N/A
Revenue Next Year
$34.88
N/A
P/E Ratio
$96.10
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.59
$4.73
52 Week High
$29.70
$9.54

Technical Indicators

Market Signals
Indicator
MUX
AURA
Relative Strength Index (RSI) 22.06 50.15
Support Level N/A $6.65
Resistance Level $20.62 $7.18
Average True Range (ATR) 0.82 0.44
MACD -0.40 -0.00
Stochastic Oscillator 0.34 40.79

Price Performance

Historical Comparison
MUX
AURA

About MUX McEwen Mining Inc.

McEwen Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. Its Other operations include: Fox Complex, Gold Bar Complex, Project Fenix, and Los Azules. The company generates its revenue from gold and silver production. Its operating segments include Canada, United States, Mexico, MSC and McEwen Copper, of which it derives maximum revenue from USA.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: